Spinal TNF elicits AMPAr trafficking and hyperalgesia
脊髓 TNF 引发 AMPAr 转运和痛觉过敏
基本信息
- 批准号:8655179
- 负责人:
- 金额:$ 33.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAcuteAnimalsBerylliumCarrageenanCell FractionationCell membraneCobaltConfocal MicroscopyCyclic AMP-Dependent Protein KinasesDataDorsalElementsEventGlutamate ReceptorGlutamatesGoalsHippocampus (Brain)HyperalgesiaImmunohistochemistryIndividualInflammationInjuryKnock-in MouseLateralLifeLinkLong-Term PotentiationMeasuresMediatingMembraneModelingMovementMusNeurogliaNeuronsNociceptionOutcomePDPK1 genePainPathway interactionsPeripheralPhosphorylationPhosphotransferasesPoint MutationPosterior Horn CellsReceptor SignalingRoleSerineSignal PathwaySiteSliceSpecific qualifier valueSpinalSpinal CordSpinal cord posterior hornStaining methodStainsSynapsesSynaptophysinTissuesTumor Necrosis Factor-alphaWestern BlottingWorkchronic paindensitydesigndorsal hornfunctional outcomesinflammatory neuropathic paininhibitor/antagonistpain behaviorpreventpublic health relevancereceptorreceptor densityresearch studyresponsetraffickingtransmission process
项目摘要
DESCRIPTION (provided by applicant): Dynamic changes in AMPA receptor (AMPAr) density and phosphorylation as well as number of Ca2+ permeable AMPAr in plasma membrane contribute to long term potentiation and synaptic strengthening. Tumor necrosis factor (TNF), a glial product, has been shown to elicit insertion of Ca2+ permeable AMPAr in plasma membrane of hippocampal neurons. In spinal cord, TNF contributes to chronic pain following a variety of injuries. The mechanism by which TNF enhances dorsal horn neuronal activity is unknown. I propose that following peripheral inflammation, glial TNF, working through a PI3K/Akt pathway, phosphorylates GluR1 subunits at 2 distinct sites, causing the AMPAr containing them to be inserted into plasma membranes. The increased AMPAr contain a disproportionate number that are Ca2+permeable, further contributing to synaptic strengthening. I will measure P-GluR1, insertion of AMPAr into the membrane and number of dorsal horn cells with functional Ca2+permeable AMPAr as a result of paw inflammation. I will use a combination of Western blots, subcellular fractionation, kainite induced cobalt loading and confocal microscopy. Spinal administration of specific inhibitors to every step in the proposed pathway will demonstrate that these elements are necessary for pain behavior and GluR1 insertion into neuronal plasma membranes as well as the sequence of events. Finally we will use 2 strains of knock in mice that do not phosphorylated GluR1 at individual serine residues. Use of these mice will further delineate the pathway and specify the necessary point of action of multi-purpose kinases. These experiments will further our understanding of fundamental spinal cord mechanisms. Ultimately, it will allow us to more logically and successfully design selective agents to treat chronic pain.
描述(由申请人提供):AMPA受体(AMPAr)密度和磷酸化的动态变化以及质膜中Ca2+可渗透AMPAr的数量有助于长期增强和突触强化。肿瘤坏死因子(TNF)是一种胶质产物,已被证明可引起海马神经元质膜上Ca2+渗透性AMPAr的插入。在脊髓中,TNF有助于多种损伤后的慢性疼痛。TNF增强背角神经元活性的机制尚不清楚。我认为,在外周炎症发生后,胶质肿瘤坏死因子通过PI3K/Akt通路,在两个不同的位点磷酸化GluR1亚基,导致含有它们的AMPAr插入质膜。增加的AMPAr含有不成比例的Ca2+渗透性,进一步促进突触加强。我将测量P-GluR1, AMPAr插入膜和由于脚掌炎症而具有功能Ca2+可渗透AMPAr的背角细胞的数量。我将使用Western blots,亚细胞分离,kainite诱导钴负载和共聚焦显微镜的组合。在提出的通路的每个步骤中,脊髓给予特定抑制剂将证明这些元素对于疼痛行为和GluR1插入神经元质膜以及事件序列是必要的。最后,我们将在小鼠中使用不磷酸化GluR1单个丝氨酸残基的2株knock。使用这些小鼠将进一步描绘途径并指定多用途激酶的必要作用点。这些实验将进一步加深我们对脊髓基本机制的理解。最终,它将使我们能够更合乎逻辑、更成功地设计出治疗慢性疼痛的选择性药物。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Carrageenan induced phosphorylation of Akt is dependent on neurokinin-1 expressing neurons in the superficial dorsal horn.
- DOI:10.1186/1744-8069-8-4
- 发表时间:2012-01-13
- 期刊:
- 影响因子:3.3
- 作者:Choi JI;Koehrn FJ;Sorkin LS
- 通讯作者:Sorkin LS
Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation.
- DOI:10.1097/j.pain.0000000000000341
- 发表时间:2016-01
- 期刊:
- 影响因子:7.4
- 作者:Pritchard RA;Falk L;Larsson M;Leinders M;Sorkin LS
- 通讯作者:Sorkin LS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA S SORKIN其他文献
LINDA S SORKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA S SORKIN', 18)}}的其他基金
Spinal TNF elicits AMPAr trafficking and hyperalgesia
脊髓 TNF 引发 AMPAr 转运和痛觉过敏
- 批准号:
7992769 - 财政年份:2010
- 资助金额:
$ 33.08万 - 项目类别:
Spinal TNF elicits AMPAr trafficking and hyperalgesia
脊髓 TNF 引发 AMPAr 转运和痛觉过敏
- 批准号:
8066344 - 财政年份:2010
- 资助金额:
$ 33.08万 - 项目类别:
Spinal TNF elicits AMPAr trafficking and hyperalgesia
脊髓 TNF 引发 AMPAr 转运和痛觉过敏
- 批准号:
8464287 - 财政年份:2010
- 资助金额:
$ 33.08万 - 项目类别:
Spinal TNF elicits AMPAr trafficking and hyperalgesia
脊髓 TNF 引发 AMPAr 转运和痛觉过敏
- 批准号:
8274704 - 财政年份:2010
- 资助金额:
$ 33.08万 - 项目类别:
Cytokine and MAP Kinase Involvement in Neuropathic Pain
细胞因子和 MAP 激酶参与神经性疼痛
- 批准号:
6873813 - 财政年份:2005
- 资助金额:
$ 33.08万 - 项目类别:
Cytokine and MAP Kinase Involvement in Neuropathic Pain
细胞因子和 MAP 激酶参与神经性疼痛
- 批准号:
7166040 - 财政年份:2005
- 资助金额:
$ 33.08万 - 项目类别:
Cytokine and MAP Kinase Involvment in Neuropathic Pain
细胞因子和 MAP 激酶参与神经性疼痛
- 批准号:
7008597 - 财政年份:2005
- 资助金额:
$ 33.08万 - 项目类别:
Cytokine and MAP Kinase Involvement in Neuropathic Pain
细胞因子和 MAP 激酶参与神经性疼痛
- 批准号:
7342878 - 财政年份:2005
- 资助金额:
$ 33.08万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Standard Grant